Search

Jerry Nick (National Jewish Health) and colleagues published a new paper on trial design for phage therapy against M. abscessus in cystic fibrosis, showing a standardized protocol to assess efficacy and safety of phage treatment in refracto

The Online Citizen wrote a piece on Singapore General Hospital's successful use of phage therapy to treat a patient using phages, which allowed the patient to avoid high-risk surgery.

We are urgently seeking Clostridium septicum phages (or any Clostridium-specific phages) for a patient with osteomyelitis in Canada. If you can help, please reach out! Ways to help at this stage: - By sending your phages (or lysins!) for

We are urgently seeking Clostridium septicum phages (or any Clostridium-specific phages) for a patient with osteomyelitis in Canada. If you can help, please reach out! Ways to help at this stage: - By sending your phages (or lysins!) for

We are urgently seeking Clostridium septicum phages (or any Clostridium-specific phages) for a patient with osteomyelitis in Canada. If you can help, please reach out! Ways to help at this stage: - By sending your phages (or lysins!) for

Huge milestone alert! BiomX has announced successful Phase II clinical trial results for their BX211 phage product against diabetic foot osteomyelitis! Subscribe to the Podovirus podcast to learn more — we'll be interviewing BiomX CEO Jona

BiomX announced positive topline safety and efficacy results from its Phase 2 DANCE trial of the BX211 phage treatment for diabetic foot osteomyelitis associated with Staphylococcus aureus. BX211 was safe and well tolerated and produced a s

The Belgian Society for Viruses of Microbes (BSVoM) is hosting their 4th Annual Symposium on Phage Research, taking place on September 12, 2025 (the day after the Phage Protein Meeting, in the same city!). Particularly, there will be also

Hanzada Nour El-Din (National Research Council Canada) and colleagues published a new paper on isolation and characterization of phages against Pseudomonas aeruginosa from cystic fibrosis patients, showing four phages with broad host range

In vitro, curcumin (400 ug/mL) combined with the newly isolated phage vB_AbaSI_1 reduced multidrug-resistant A. baumannii to undetectable levels within 1 hour, and a double dose extended this to 5 hours, whereas phage alone rebounded within

Maciej Żaczek (Hirszfeld Institute of Immunology and Experimental Therapy) and colleagues published a new paper on Polish perceptions of phage therapy, showing awareness of phage therapy varies significantly by education level, with 84.4% o

After an announcement last month that Canada would close its phage therapy research program at the National Microbiology Lab in Winnipeg, Michael Parcey and colleagues have announced a ‘stunning reversal’: a set of unexpected, last-minute c

Phage cocktail or personalized therapy — an age-old binary, or a spectrum after all? Minyoung Kevin Kim (Stanford University) and colleagues from Mayo Clinic, QAMH, & KU Leuven published a review on how phage therapy is currently being impl

Andrea Kwa (Singapore General Hospital) and colleagues have announced Singapore’s second phage therapy case.

Micreos Pharmaceuticals partners with biologics CDMO Northway Biotech for its engineered endolysin therapeutic manufacturing program. The partnership will develop scalable cGMP production processes for MEndoB, an investigational therapeutic

We are urgently seeking Burkholderia and Klebsiella phages for two patients in the USA. If you can help with one or both, please reach out! Ways to help at this stage: - By sending your phages for testing on the patient's strains - By rec

We are urgently seeking Burkholderia and Klebsiella phages for two patients in the USA. If you can help with one or both, please reach out! Ways to help at this stage: - By sending your phages for testing on the patient's strains - By rec

Melissa Cammuso (The Ottawa Hospital) and colleagues have published a preprint in medRxiv on the first use of phage therapy in Canada for life-threatening, MDR Staphylococcus epidermidis periprosthetic joint infection. This ‘n of 1 trial’ d

Los Angeles Biotech startup Parallel Health has announced an expanded protocol for personalized skin treatments using microbiome science and phage therapy. Their approach combines microbiome testing, custom phage serums, telehealth, and pre

We are urgently seeking Burkholderia and Klebsiella phages for two patients in the USA. If you can help with one or both, please reach out! Ways to help at this stage: - By sending your phages for testing on the patient's strains - By rec